Mainstay Medical completes enrollment in spinal cord stimulator trial

Spinal Tech

Mainstay Medical completed enrollment for its randomized clinical trial for its ReActiv8 restorative neurostimulation device, according to an Aug. 29 news release.

The study will evaluate ReActiv8 compared to a patient's optimal medical management, according to a news release. ReActiv8 is designed to help patients with intractable chronic low back pain.

The trial will be done at 25 centers in the U.S.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers